Dolcanatide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDolcanatide
Drug Alias Namedolcanatida多卡那肽度卡那肽dolcanatidedolcanatidum +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHeat-stable enterotoxin receptor agonists
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsConstipation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynergy Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Americas Inc
Active IndicationsN/A
Inactive IndicationsConstipation

Other Information

ATC CodeN/A
Related LinksN/A